Goodwin Biotechnology

Goodwin Biotechnology, Inc. (GBI), based near Fort Lauderdale, Florida, is a fully integrated, customer-focused cGMP Contract Manufacturing Organization (CMO) specialising in the production of biosimilar and innovative monoclonal antibodies, recombinant proteins, vaccines, Antibody Drug Conjugates (ADCs), and other bioconjugates. As a provider to the pharmaceutical industry, Goodwin Biotechnology prides itself on adhering to the highest standards of quality and compliance in the biopharmaceutical manufacturing process.

Services include:
- Biosimilar and innovative monoclonal antibody manufacturing
- Recombinant protein production
- Vaccine development and manufacturing
- Antibody Drug Conjugates (ADCs)
- Bioconjugate manufacturing
- Finished dosage formulation
- Packaging solutions

Goodwin Biotechnology is committed to delivering exceptional contract manufacturing services tailored to the unique needs of its clients in the pharmaceutical sector. For further information, please visit goodwinbio.com.